Shall we treat all patients with hepatitis C, and if not, why? Certainly, injecting drug users must not be an exclusion criterion
- PMID: 19023206
- DOI: 10.1159/000173732
Shall we treat all patients with hepatitis C, and if not, why? Certainly, injecting drug users must not be an exclusion criterion
Comment on
-
Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs.Digestion. 2008;78(2-3):123-30. doi: 10.1159/000173733. Epub 2008 Nov 21. Digestion. 2008. PMID: 19023207 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
